IGC Pharma, Inc. (IGC)
0.2797
0.00 (0.00%)
USD |
NYAM |
Oct 08, 16:00
0.2854
+0.01
(+2.04%)
After-Hours: 17:51
IGC Pharma Market Cap : 28.65M for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 28.68M |
| October 06, 2026 | 28.68M |
| October 05, 2026 | 28.88M |
| October 02, 2026 | 28.15M |
| October 01, 2026 | 27.65M |
| September 30, 2026 | 27.54M |
| September 29, 2026 | 27.40M |
| September 28, 2026 | 28.06M |
| September 25, 2026 | 28.92M |
| September 24, 2026 | 28.79M |
| September 23, 2026 | 29.30M |
| September 22, 2026 | 28.98M |
| September 21, 2026 | 28.06M |
| September 18, 2026 | 29.19M |
| September 17, 2026 | 27.28M |
| September 16, 2026 | 27.86M |
| September 15, 2026 | 27.34M |
| September 14, 2026 | 28.22M |
| September 11, 2026 | 28.53M |
| September 10, 2026 | 28.98M |
| September 09, 2026 | 28.83M |
| September 08, 2026 | 29.69M |
| September 04, 2026 | 30.52M |
| September 03, 2026 | 30.57M |
| September 02, 2026 | 30.31M |
| Date | Value |
|---|---|
| September 01, 2026 | 30.39M |
| August 31, 2026 | 30.64M |
| August 28, 2026 | 31.75M |
| August 27, 2026 | 34.20M |
| August 26, 2026 | 31.51M |
| August 25, 2026 | 31.20M |
| August 24, 2026 | 30.79M |
| August 21, 2026 | 31.54M |
| August 20, 2026 | 28.39M |
| August 19, 2026 | 29.22M |
| August 18, 2026 | 29.13M |
| August 17, 2026 | 28.68M |
| August 14, 2026 | 30.50M |
| August 13, 2026 | 30.11M |
| August 12, 2026 | 29.28M |
| August 11, 2026 | 27.76M |
| August 10, 2026 | 26.43M |
| August 07, 2026 | 25.35M |
| August 06, 2026 | 24.69M |
| August 05, 2026 | 24.90M |
| August 04, 2026 | 24.50M |
| August 03, 2026 | 24.21M |
| July 31, 2026 | 24.60M |
| July 30, 2026 | 24.65M |
| July 29, 2026 | 23.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 14.62M |
| CNBX Pharmaceuticals, Inc. | 0.2361M |
| Arvinas, Inc. | 490.73M |
| Fulcrum Therapeutics, Inc. | 286.45M |
| Definium Therapeutics, Inc. | 4.593B |
Market Cap Related Metrics
| PS Ratio | 23.85 |
| PEG Ratio | -0.0823 |
| Price to Book Value | 4.672 |
| Price | 0.2797 |
| Earnings Yield | -29.17% |
| PEGY Ratio | -0.0823 |